Examination of the additive value of CTC biomarkers of Heterogeneity (Het) and Chromosomal Instability to Nuclear localized ( nl ) AR V7+ CTCs in prediction of poor outcomes to Androgen Receptor signaling inhibitor (ARSi) in Metastatic Castration Resistant Prostate Cancer (mCRPC).2019-06-10T12:44:52-07:00
Examination of the additive value of CTC biomarkers of Heterogeneity (Het) and Chromosomal Instability to Nuclear localized ( nl ) AR V7+ CTCs in prediction of poor outcomes to Androgen Receptor signaling inhibitor (ARSi) in Metastatic Castration Resistant Prostate Cancer (mCRPC)
